Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer

nork Barrière, Jérôme, Re, Daniel, Peyrade, Frédéric, Carles, Michel
Argitaratua izan da Eur J Cancer (2021)

Hodgkin’s Lymphoma in Older Patients: an Orphan Disease?

nork Thyss, Antoine, Saada, Esma, Gastaud, Lauris, Peyrade, Frédéric, Re, Daniel
Argitaratua 2014

Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer

nork Thariat, Juliette, Launay-Vacher, Vincent, Italiano, Antoine, Santini, José, Peyrade, Frederic
Argitaratua izan da NDT Plus (2008)

Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation

nork Peyrade, Frederic, Re, Daniel, Ginet, Clemence, Gastaud, Lauris, Allegra, Maryline, Ballotti, Robert, Thyss, Antoine, Zenz, Thorsten, Auberger, Patrick, Robert, Guillaume
Argitaratua 2013

Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib

nork Bailleux, Caroline, Robert, Guillaume, Ginet, Clémence, Re, Daniel, Thyss, Antoine, Sudaka, Isabelle, Peyrottes, Isabelle, Hofman, Paul, Auberger, Patrick, Peyrade, Frederic
Argitaratua izan da Oncoscience (2014)

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphom...

nork Tardy, Magalie P., Gastaud, Lauris, Ojeda-Uribe, Mario, Boscagli, Annick, Caruso, Salvatore, Skaf, Richard, Gutnecht, Jean, Thyss, Antoine, Peyrade, Frédéric
Argitaratua izan da Exp Hematol Oncol (2015)

Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

nork Refae, Sadal, Gal, Jocelyn, Brest, Patrick, Giacchero, Damien, Borchiellini, Delphine, Ebran, Nathalie, Peyrade, Frederic, Guigay, Joël, Milano, Gérard, Saada-Bouzid, Esma
Argitaratua izan da Sci Rep (2020)

Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

nork Refae, Sadal, Gal, Jocelyn, Brest, Patrick, Giacchero, Damien, Borchiellini, Delphine, Ebran, Nathalie, Peyrade, Frederic, Guigay, Joël, Milano, Gérard, Saada-Bouzid, Esma
Argitaratua izan da Sci Rep (2020)

Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma

nork Schoof, Nils, Franklin, Jeremy, Fürst, Robert, Zander, Thomas, von Bonin, Frederike, Peyrade, Frederic, Trümper, Lorenz, Diehl, Volker, Engert, Andreas, Kube, Dieter, Re, Daniel
Argitaratua 2013

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway

nork Robert, Guillaume, Jullian, Valérie, Jacquel, Arnaud, Ginet, Clémence, Dufies, Maeva, Torino, Stephanie, Pottier, Anaïs, Peyrade, Frederic, Tartare-Deckert, Sophie, Bourdy, Geneviève, Deharo, Eric, Auberger, Patrick
Argitaratua 2012

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03

nork Fayette, Jerome, Guigay, Joel, Tourneau, Christophe Le, Degardin, Marian, Peyrade, Frederic, Neidhardt, Eve-Marie, Sablin, Marie-Paule, Even, Caroline, Orlandini, Florence, Juzyna, Béata, Bellera, Carine
Argitaratua izan da Oncotarget (2017)

DPD status and fluoropyrimidines-based treatment: high activity matters too

nork Chamorey, Emmanuel, Francois, Eric, Etienne, Marie-Christine, Ferrero, Jean-Marc, Peyrade, Frederic, Barranger, Emmanuel, Bozec, Alexandre, Largillier, Rémy, Cassuto, Ophelie, Viotti, Julien, Schiappa, Renaud, Milano, Gérard
Argitaratua izan da BMC Cancer (2020)

Nous devons respecter le schéma vaccinal anti-SARS-CoV-2 sans décalage chez les patients atteints de cancer sous traitement

nork Barrière, Jérôme, Audigier-Valette, Clarisse, Borchiellini, Delphine, Hoch, Benjamin, Castelnau, Olivier, Francois, Eric, Gastaud, Lauris, Skaf, Richard, Berdah, Jean-François, Marie, Wislez, Lescaut, Willy, Peyrade, Frédéric, Cluzeau, Thomas, Cassuto, Ophélie, Carles, Michel
Argitaratua izan da Bull Cancer (2021)

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME

nork Chevalier, Thomas, Daste, Amaury, Saada‐Bouzid, Esmaa, Loundou, Anderson, Peyraud, Florent, Lambert, Tiphaine, Le Tourneau, Christophe, Peyrade, Frédéric, Dupuis, Charlotte, Alfonsi, Marc, Fayette, Jérôme, Reure, Juliette, Huguet, Florence, Fakhry, Nicolas, Toullec, Clémence, Salas, Sébastien
Argitaratua izan da Cancer Med (2021)

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study

nork Montaudié, Henri, Viotti, Julien, Combemale, Patrick, Dutriaux, Caroline, Dupin, Nicolas, Robert, Caroline, Mortier, Laurent, Kaphan, Régis, Duval-Modeste, Anne-Bénédicte, Dalle, Stéphane, De Quatrebarbes, Julie, Stefan, Andrea, Brunet-Possenti, Florence, Kogay, Maria, Picard-Gauci, Alexandra, Poissonnet, Gilles, Peyrade, Frédéric
Argitaratua izan da Oncotarget (2020)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

nork Cabannes‐Hamy, Aurélie, Peyrade, Frederic, Jardin, Fabrice, Emile, Jean‐François, Delwail, Vincent, Mounier, Nicolas, Haioun, Corinne, Perrot, Aurore, Fitoussi, Olivier, Lara, Diane, Delarue, Richard, André, Marc, Offner, Fritz, Ghesquières, Hervé, Pascal, Laurent, Soussain, Carole, Lazarovici, Julien, Schiano, Jean‐Marc, Gaulard, Philippe, Tilly, Hervé, Thieblemont, Catherine
Argitaratua izan da Cancer Med (2018)

FCGR3A/2A polymorphisms and Diffuse Large B-cell Lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1,134 patients from two prospective cohorts

nork Ghesquières, Hervé, Larrabee, Beth R., Haioun, Corinne, Link, Brian K., Verney, Aurélie, Slager, Susan L., Ketterer, Nicolas, Ansell, Stephen M., Delarue, Richard, Maurer, Matthew J., Fitoussi, Olivier, Habermann, Thomas M., Peyrade, Fréderic, Dogan, Ahmet, Molina, Thierry J., Novak, Anne J., Tilly, Hervé, Cerhan, James R., Salles, Gilles
Argitaratua izan da Hematol Oncol (2016)

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

nork Lazarovici, Julien, Dartigues, Peggy, Brice, Pauline, Obéric, Lucie, Gaillard, Isabelle, Hunault-Berger, Mathilde, Broussais-Guillaumot, Florence, Gyan, Emmanuel, Bologna, Serge, Nicolas-Virelizier, Emmanuelle, Touati, Mohamed, Casasnovas, Olivier, Delarue, Richard, Orsini-Piocelle, Frédérique, Stamatoullas, Aspasia, Gabarre, Jean, Fornecker, Luc-Matthieu, Gastinne, Thomas, Peyrade, Fréderic, Roland, Virginie, Bachy, Emmanuel, André, Marc, Mounier, Nicolas, Fermé, Christophe
Argitaratua izan da Haematologica (2015)

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

nork Maurer, Matthew J., Ghesquières, Hervé, Jais, Jean-Philippe, Witzig, Thomas E., Haioun, Corinne, Thompson, Carrie A., Delarue, Richard, Micallef, Ivana N., Peyrade, Frédéric, Macon, William R., Jo Molina, Thierry, Ketterer, Nicolas, Syrbu, Sergei I., Fitoussi, Olivier, Kurtin, Paul J., Allmer, Cristine, Nicolas-Virelizier, Emmanuelle, Slager, Susan L., Habermann, Thomas M., Link, Brian K., Salles, Gilles, Tilly, Hervé, Cerhan, James R.
Argitaratua 2014

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials

nork Maurer, Matthew J., Ghesquières, Hervé, Link, Brian K., Jais, Jean-Philippe, Habermann, Thomas M., Thompson, Carrie A., Haioun, Corinne, Allmer, Cristine, Johnston, Patrick B., Delarue, Richard, Micallef, Ivana N., Peyrade, Frederic, Inwards, David J., Ketterer, Nicolas, Farooq, Umar, Fitoussi, Olivier, Macon, William R., Molina, Thierry J., Syrbu, Sergei, Feldman, Andrew L., Slager, Susan L., Weiner, George J., Ansell, Stephen M., Cerhan, James R., Salles, Gilles A., Witzig, Thomas E., Tilly, Hervé, Nowakowski, Grzegorz S.
Argitaratua izan da J Clin Oncol (2018)